Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines

Elissa M. Ozanne(Tufts University), Brian Drohan(Tufts University), Phil Bosinoff(Tufts University), Alan Semine(Tufts University), Michael S. Jellinek(Tufts University), Claire Cronin(Tufts University), Frederick H. Millham(Tufts University), Dana Dowd(Tufts University), Taryn Rourke(Tufts University), Caroline Block(Tufts University), Kevin S. Hughes(Tufts University)
Cancer Epidemiology Biomarkers & Prevention
November 15, 2012
Cited by 70Open Access
Full Text

Abstract

The American Cancer Society (ACS) guidelines define the appropriate use of MRI as an adjunct to mammography for breast cancer screening. Three risk assessment models are recommended to determine if women are at sufficient risk to warrant the use of this expensive screening tool, however, the real-world application of these models has not been explored. We sought to understand how these models behave in a community setting for women undergoing mammography screening. We conducted a retrospective analysis of 5,894 women, who received mammography screening at a community hospital and assessed their eligibility for MRI according to the ACS guidelines. Of the 5,894 women, 342 (5.8%) were eligible for MRI, but we found significant differences in the number of eligible women identified by each model. Our results indicate that these models identify very different populations, implying that the ACS guidelines deserve further development and consideration.


Related Papers

No related papers found

Powered by citation graph analysis